Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Treatment Options in Oncology|February 19, 2005
Utilizing prognostic and predictive factors in breast cancerDeepa S Subramaniam, Claudine IsaacsDiscovery Medicine|May 17, 2019
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an updateSushma Jonna, Deepa S SubramaniamExpert Opinion on Investigational Drugs|February 16, 2011
BIBW 2992 in non-small cell lung cancerDeepa S Subramaniam, Jimmy HwangDiscovery Medicine|September 29, 2018
Understanding molecular diagnostic technology in oncology through the lens of lung cancerSushma Jonna, Giuseppe Giaccone, Deepa S SubramaniamDiscovery Medicine|May 28, 2016
Novel approaches in cancer immunotherapyDeepa S Subramaniam, Stephen V Liu, Giuseppe GiacconeExpert Opinion on Investigational Drugs|December 7, 2016
Ganetespib for small cell lung cancerDeepa S Subramaniam, Eiran A Warner, Giuseppe GiacconeFrontiers in Oncology|July 19, 2018
Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung CancerWilliam J Kelly, Neil J Shah, Deepa S SubramaniamNature Reviews. Clinical Oncology|May 13, 2015
Refining the treatment of NSCLC according to histological and molecular subtypesAnish Thomas, Stephen V Liu, Deepa S Subramaniam, et al.Frontiers in Oncology|March 30, 2018
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung CancerDeepa S Subramaniam, Stephen V Liu, Jeanette Crawford, et al.Journal for Immunotherapy of Cancer|July 4, 2020
Phase I study of the <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lungChul Kim, Stephen V Liu, Deepa S Subramaniam, et al.Pageof 3